Skip to ContentSkip to Navigation
Practical matters How to find us N.H.B. (Nic) Schräder


The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study

1+1=3, ervaringen van UMCG onderzoekers met de training patiëntenparticipatie

Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

Identifying Epidermolysis Bullosa Patient Needs and Perceived Treatment Benefits: An Explorative Study Using the Patient Benefit Index

Letter to the Editor: Ordering the Chaos in Cannabinoid-Related Research: Is It Time for a Task Force on Taxonomy?

Combined THC and CBD to treat pain in epidermolysis bullosa: a report of three cases

The Pain Quality Assessment Scale for epidermolysis bullosa

Read more


UMCG starts scientific research into cannabis oil for chronic pain in Epidermolysis Bullosa

Exploring Cannabinoid medicines to treat Pain & Itch in Adults with Epidermolysis Bullosa